PT837679E - Derivados 2-(1h-4(5)-imidazoil)ciclopropilo - Google Patents

Derivados 2-(1h-4(5)-imidazoil)ciclopropilo Download PDF

Info

Publication number
PT837679E
PT837679E PT96914788T PT96914788T PT837679E PT 837679 E PT837679 E PT 837679E PT 96914788 T PT96914788 T PT 96914788T PT 96914788 T PT96914788 T PT 96914788T PT 837679 E PT837679 E PT 837679E
Authority
PT
Portugal
Prior art keywords
imidazol
compound
cyclopropyl
pharmaceutically acceptable
triphenylmethyl
Prior art date
Application number
PT96914788T
Other languages
English (en)
Portuguese (pt)
Inventor
James G Phillips
Clark E Tedford
Amin Mohammed Khan
Stephen L Yates
Original Assignee
Gliatech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gliatech Inc filed Critical Gliatech Inc
Publication of PT837679E publication Critical patent/PT837679E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Paints Or Removers (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT96914788T 1995-05-30 1996-05-29 Derivados 2-(1h-4(5)-imidazoil)ciclopropilo PT837679E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/453,359 US5652258A (en) 1995-05-30 1995-05-30 2-(4-imidazoyl) cyclopropyl derivatives

Publications (1)

Publication Number Publication Date
PT837679E true PT837679E (pt) 2002-03-28

Family

ID=23800267

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96914788T PT837679E (pt) 1995-05-30 1996-05-29 Derivados 2-(1h-4(5)-imidazoil)ciclopropilo

Country Status (17)

Country Link
US (2) US5652258A (cg-RX-API-DMAC10.html)
EP (1) EP0837679B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001503013A (cg-RX-API-DMAC10.html)
KR (1) KR19990022137A (cg-RX-API-DMAC10.html)
CN (1) CN1100534C (cg-RX-API-DMAC10.html)
AT (1) ATE207354T1 (cg-RX-API-DMAC10.html)
AU (1) AU713767B2 (cg-RX-API-DMAC10.html)
CA (1) CA2222101A1 (cg-RX-API-DMAC10.html)
DE (1) DE69616328T2 (cg-RX-API-DMAC10.html)
DK (1) DK0837679T3 (cg-RX-API-DMAC10.html)
ES (1) ES2163019T3 (cg-RX-API-DMAC10.html)
FI (1) FI974363A0 (cg-RX-API-DMAC10.html)
MX (1) MX9709211A (cg-RX-API-DMAC10.html)
NO (1) NO975484D0 (cg-RX-API-DMAC10.html)
NZ (1) NZ308410A (cg-RX-API-DMAC10.html)
PT (1) PT837679E (cg-RX-API-DMAC10.html)
WO (1) WO1996038141A1 (cg-RX-API-DMAC10.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652258A (en) * 1995-05-30 1997-07-29 Gliatech, Inc. 2-(4-imidazoyl) cyclopropyl derivatives
US6008240A (en) * 1997-12-15 1999-12-28 Gliatech, Inc. 2-(1H-4(5)-imidazoyl) cyclopropyl derivatives
WO2000042023A1 (en) 1999-01-18 2000-07-20 Novo Nordisk A/S Substituted imidazoles, their preparation and use
US7265115B2 (en) 1999-01-29 2007-09-04 Abbott Laboratories Diazabicyclic CNS active agents
US6908926B1 (en) 1999-04-16 2005-06-21 Novo Nordisk A/S Substituted imidazoles, their preparation and use
US6114350A (en) * 1999-04-19 2000-09-05 Nen Life Science Products, Inc. Cyanine dyes and synthesis methods thereof
US6610721B2 (en) 2000-03-17 2003-08-26 Novo Nordisk A/S Imidazo heterocyclic compounds
US6437147B1 (en) 2000-03-17 2002-08-20 Novo Nordisk Imidazole compounds
EP1313470A4 (en) 2000-08-17 2005-02-16 Gliatech Inc NEW ALICYCLIC IMIDAZOLE AS H 3 ACTIVE SUBSTANCES
EP1320364A1 (en) * 2000-08-21 2003-06-25 Gliatech, Inc. The use of histamine h3-receptor inverse agonists for the control of appetite and treatment of obesity
WO2002067938A2 (en) * 2000-10-30 2002-09-06 Schering Corporation Treating or reducing the risk of cardiovascular disease
AU2003248584A1 (en) * 2002-03-01 2003-09-16 Warner-Lambert Company Llc Method of treating osteoarthritis
EP1720847A1 (en) * 2004-02-02 2006-11-15 Pfizer Products Incorporated Histamine-3 receptor modulators
US7902191B2 (en) 2004-02-25 2011-03-08 Eli Lilly And Company Histamine H3 receptor antagonists, preparation and therapeutic uses
CA2561628C (en) 2004-04-01 2012-05-08 Eli Lilly And Company Histamine h3 receptor agents, preparation and therapeutic uses
CN1956952B (zh) * 2004-06-02 2013-12-11 伊莱利利公司 组胺h3受体药剂、制备和治疗学用途
EP1784400B1 (en) 2004-08-23 2015-01-14 Eli Lilly And Company Histamine h3 receptor agents, preparation and therapeutic uses
WO2006044228A1 (en) 2004-10-18 2006-04-27 Eli Lilly And Company Histamine h3 receptor inhibitors, preparation and therapeutic uses
DE602006010833D1 (de) * 2005-03-17 2010-01-14 Lilly Co Eli Pyrrolidinderivate als histamin-h3-rezeptorantagonisten
EP1707203A1 (en) 2005-04-01 2006-10-04 Bioprojet Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands
CN101151244B (zh) 2005-04-01 2014-09-03 伊莱利利公司 组胺h3受体活性剂、制备和治疗用途
EP1717233A1 (en) * 2005-04-29 2006-11-02 Bioprojet Histamine H3-receptor ligands and their therapeutic application
EP1717235A3 (en) 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
US20100137391A1 (en) * 2005-09-15 2010-06-03 Ryo Yoshimoto Histamine H3 Agonist for use as Therapeutic Agent for a Lipid/Glucose Metabolic Disorder
EP1942104A1 (en) * 2006-12-20 2008-07-09 sanofi-aventis Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
US8993808B2 (en) 2009-01-21 2015-03-31 Oryzon Genomics, S.A. Phenylcyclopropylamine derivatives and their medical use
WO2011035941A1 (en) 2009-09-25 2011-03-31 Oryzon Genomics S.A. Lysine specific demethylase-1 inhibitors and their use
US8946296B2 (en) 2009-10-09 2015-02-03 Oryzon Genomics S.A. Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
WO2011106574A2 (en) 2010-02-24 2011-09-01 Oryzon Genomics, S.A. Inhibitors for antiviral use
WO2011106106A2 (en) 2010-02-24 2011-09-01 Oryzon Genomics, S.A. Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
RS55348B1 (sr) 2010-04-19 2017-03-31 Oryzon Gnomics S A Inhibitori lizin specifične demetilaze-1 i njihova upotreba
EP2598480B1 (en) 2010-07-29 2019-04-24 Oryzon Genomics, S.A. Cyclopropylamine derivatives useful as lsd1 inhibitors
DK2598482T3 (en) 2010-07-29 2018-06-14 Oryzon Genomics Sa ARYLCYCLOPROPYLAMINE-BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE
WO2012045883A1 (en) 2010-10-08 2012-04-12 Oryzon Genomics S.A. Cyclopropylamine inhibitors of oxidases
WO2012072713A2 (en) 2010-11-30 2012-06-07 Oryzon Genomics, S.A. Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
EP2712315B1 (en) 2011-02-08 2021-11-24 Oryzon Genomics, S.A. Lysine demethylase inhibitors for myeloproliferative disorders
US9469597B2 (en) 2011-10-20 2016-10-18 Oryzon Genomics S.A. (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
AU2012324803B9 (en) 2011-10-20 2017-08-24 Oryzon Genomics, S.A. (hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2579596B1 (fr) * 1985-03-26 1987-11-20 Inst Nat Sante Rech Med (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
FR2671083B1 (fr) * 1990-12-31 1994-12-23 Inst Nat Sante Rech Med Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques.
EP0573542B1 (en) * 1991-02-27 1997-10-15 Seed Capital Investments( Sci) B.V. Imidazole-derivatives having antagonistic activity on the histamine h3-receptor
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
US5217986A (en) * 1992-03-26 1993-06-08 Harbor Branch Oceanographic Institution, Inc. Anti-allergy agent
US5652258A (en) * 1995-05-30 1997-07-29 Gliatech, Inc. 2-(4-imidazoyl) cyclopropyl derivatives

Also Published As

Publication number Publication date
DE69616328D1 (de) 2001-11-29
FI974363L (fi) 1997-11-28
DE69616328T2 (de) 2002-07-04
FI974363A7 (fi) 1997-11-28
US5990317A (en) 1999-11-23
MX9709211A (es) 1998-07-31
EP0837679A4 (en) 1999-03-03
AU713767B2 (en) 1999-12-09
DK0837679T3 (da) 2002-02-11
EP0837679B1 (en) 2001-10-24
NZ308410A (en) 2001-06-29
FI974363A0 (fi) 1997-11-28
EP0837679A1 (en) 1998-04-29
JP2001503013A (ja) 2001-03-06
ATE207354T1 (de) 2001-11-15
WO1996038141A1 (en) 1996-12-05
CA2222101A1 (en) 1996-12-05
AU5804796A (en) 1996-12-18
ES2163019T3 (es) 2002-01-16
CN1100534C (zh) 2003-02-05
CN1192143A (zh) 1998-09-02
NO975484D0 (no) 1997-11-28
US5652258A (en) 1997-07-29
KR19990022137A (ko) 1999-03-25

Similar Documents

Publication Publication Date Title
EP0837679B1 (en) 2-(1h-4(5)-imidazoyl) cyclopropyl derivatives
AU721325B2 (en) 1H-4(5)-substituted imidazole derivatives
JP7652865B2 (ja) Ｒｏｃｋ阻害剤としての重水素化合物
RU2351588C2 (ru) Производные n-фенил(пиперидин-2-ил)метил-бензамида и их применение в терапии
CN103200941B (zh) 用于降低眼内压的[3-(1-(1h-咪唑-4-基)乙基)-2-甲基苯基]甲醇的酯前药
US5811431A (en) Spiro-substituted azacyclic derivatives and their use as therapeutic agents
US6069176A (en) Phenylethanolamine compounds useful as β 3 agonists, process for producing the same, and intermediates in the production of the same
TW533211B (en) Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
JPWO2003002554A1 (ja) ピペラジン化合物
AU2013215468A1 (en) Benzyl sulfonamide derivatives useful as MOGAT - 2 inhibitors
US6448282B1 (en) 1H-4(5)-substituted imidazole derivatives
WO2018140504A1 (en) Compositions and methods for blocking sodium channels
AU713166B2 (en) 1H-4(5)-substituted imidazole derivatives
US6008240A (en) 2-(1H-4(5)-imidazoyl) cyclopropyl derivatives
NZ231243A (en) Diphenylalkylamide derivatives and pharmaceutical compositions thereof
JP4781362B2 (ja) ４級アンモニウム基を有するキヌクリジン化合物とその調製方法、およびアセチルコリン遮断剤としての用途
CN101389617A (zh) 制备哌嗪基和二氮杂环庚烷基苯甲酰胺衍生物的新方法
RU2114828C1 (ru) Энантиомеры ароматических азотсодержащих производных и их соли с неорганическими или органическими кислотами и способ их получения
PT94298B (pt) Processo para a preparacao de derivados de 4, 5, 5a, 6-tetra-hidro-3h-isoxazolo{5,4,3-k1}acridinas e de composicoes farmaceuticas que os contem
MXPA97009210A (en) Derivatives of imidazol ih-4 (5) -substitui
US20200181067A1 (en) Fluorinated amide derivatives and their uses as therapeutic agents
MXPA01008119A (en) (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same